Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cross-sectional) and their ability to predict mortality and major adverse cardiac events (longitudinal) in patients with chronic CAD.

Inclusion Criteria:

• Age >18 years
• Undergoing clinically indicated CCTA with >64-detector row CT
• Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation

Exclusion Criteria:

• Individuals unable to provide informed consent
• Non-cardiac illness with life expectancy < 2 years
• Pregnancy